General Information of Drug Transporter (DT)
DT ID DTD0092 Transporter Info
Gene Name SLC13A2
Transporter Name Sodium/dicarboxylate cotransporter 1
Gene ID
9058
UniProt ID
Q13183
Post-Translational Modification of This DT
Overview of SLC13A2 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X: Amino Acid

Phosphorylation

  Serine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC13A2 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

333

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC13A2 Serine 333 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC13A2 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

386

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC13A2 Serine 386 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC13A2 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

345

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC13A2 Threonine 345 has the potential to affect its expression or activity.
References
1 Quantitative phospho-proteomics to investigate the polo-like kinase 1-dependent phospho-proteome. Mol Cell Proteomics. 2011 Nov;10(11):M111.008540.
2 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.